vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and FORMFACTOR INC (FORM). Click either name above to swap in a different company.

FORMFACTOR INC is the larger business by last-quarter revenue ($226.1M vs $121.8M, roughly 1.9× Core Laboratories Inc.). FORMFACTOR INC runs the higher net margin — 9.0% vs 4.2%, a 4.8% gap on every dollar of revenue. On growth, FORMFACTOR INC posted the faster year-over-year revenue change (32.0% vs -1.4%). FORMFACTOR INC produced more free cash flow last quarter ($30.7M vs $517.0K). Over the past eight quarters, FORMFACTOR INC's revenue compounded faster (7.0% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Formfactor, Inc. is a provider of test and measurement technologies for integrated circuits, with its headquarters in Livermore, California. It provides semiconductor companies with products to improve device performance and provide test and measurement technologies for integrated circuits.

CLB vs FORM — Head-to-Head

Bigger by revenue
FORM
FORM
1.9× larger
FORM
$226.1M
$121.8M
CLB
Growing faster (revenue YoY)
FORM
FORM
+33.4% gap
FORM
32.0%
-1.4%
CLB
Higher net margin
FORM
FORM
4.8% more per $
FORM
9.0%
4.2%
CLB
More free cash flow
FORM
FORM
$30.2M more FCF
FORM
$30.7M
$517.0K
CLB
Faster 2-yr revenue CAGR
FORM
FORM
Annualised
FORM
7.0%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
FORM
FORM
Revenue
$121.8M
$226.1M
Net Profit
$5.1M
$20.4M
Gross Margin
38.4%
Operating Margin
1.5%
7.4%
Net Margin
4.2%
9.0%
Revenue YoY
-1.4%
32.0%
Net Profit YoY
218.5%
EPS (diluted)
$0.11
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
FORM
FORM
Q1 26
$121.8M
$226.1M
Q4 25
$138.3M
$215.2M
Q3 25
$134.5M
$202.7M
Q2 25
$130.2M
$195.8M
Q1 25
$123.6M
$171.4M
Q4 24
$129.2M
$189.5M
Q3 24
$134.4M
$207.9M
Q2 24
$130.6M
$197.5M
Net Profit
CLB
CLB
FORM
FORM
Q1 26
$5.1M
$20.4M
Q4 25
$4.9M
$23.2M
Q3 25
$14.2M
$15.7M
Q2 25
$10.6M
$9.1M
Q1 25
$-154.0K
$6.4M
Q4 24
$7.4M
$9.7M
Q3 24
$11.7M
$18.7M
Q2 24
$9.0M
$19.4M
Gross Margin
CLB
CLB
FORM
FORM
Q1 26
38.4%
Q4 25
20.8%
42.2%
Q3 25
22.0%
39.8%
Q2 25
20.3%
37.3%
Q1 25
19.5%
37.7%
Q4 24
17.8%
38.8%
Q3 24
20.5%
40.7%
Q2 24
21.2%
44.0%
Operating Margin
CLB
CLB
FORM
FORM
Q1 26
1.5%
7.4%
Q4 25
11.5%
10.9%
Q3 25
15.6%
8.9%
Q2 25
11.7%
6.3%
Q1 25
3.6%
1.9%
Q4 24
11.0%
4.1%
Q3 24
14.7%
8.6%
Q2 24
12.3%
9.0%
Net Margin
CLB
CLB
FORM
FORM
Q1 26
4.2%
9.0%
Q4 25
3.6%
10.8%
Q3 25
10.6%
7.7%
Q2 25
8.2%
4.6%
Q1 25
-0.1%
3.7%
Q4 24
5.7%
5.1%
Q3 24
8.7%
9.0%
Q2 24
6.9%
9.8%
EPS (diluted)
CLB
CLB
FORM
FORM
Q1 26
$0.11
$0.26
Q4 25
$0.11
$0.29
Q3 25
$0.30
$0.20
Q2 25
$0.22
$0.12
Q1 25
$0.00
$0.08
Q4 24
$0.15
$0.12
Q3 24
$0.25
$0.24
Q2 24
$0.19
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
FORM
FORM
Cash + ST InvestmentsLiquidity on hand
$22.8M
$123.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$1.1B
Total Assets
$587.7M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
FORM
FORM
Q1 26
$22.8M
$123.5M
Q4 25
$22.7M
$103.3M
Q3 25
$25.6M
$266.0M
Q2 25
$31.2M
$249.3M
Q1 25
$22.1M
$299.0M
Q4 24
$19.2M
$360.0M
Q3 24
$21.5M
$354.5M
Q2 24
$17.7M
$357.6M
Total Debt
CLB
CLB
FORM
FORM
Q1 26
Q4 25
$110.3M
$12.2M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
$13.3M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
FORM
FORM
Q1 26
$275.1M
$1.1B
Q4 25
$266.0M
$1.0B
Q3 25
$271.3M
$1.0B
Q2 25
$261.3M
$990.0M
Q1 25
$253.4M
$965.9M
Q4 24
$246.6M
$947.8M
Q3 24
$250.7M
$955.0M
Q2 24
$240.3M
$947.9M
Total Assets
CLB
CLB
FORM
FORM
Q1 26
$587.7M
$1.3B
Q4 25
$584.0M
$1.2B
Q3 25
$591.4M
$1.2B
Q2 25
$602.1M
$1.2B
Q1 25
$591.5M
$1.2B
Q4 24
$585.1M
$1.1B
Q3 24
$600.5M
$1.2B
Q2 24
$597.8M
$1.2B
Debt / Equity
CLB
CLB
FORM
FORM
Q1 26
Q4 25
0.41×
0.01×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
0.01×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
FORM
FORM
Operating Cash FlowLast quarter
$4.0M
$45.0M
Free Cash FlowOCF − Capex
$517.0K
$30.7M
FCF MarginFCF / Revenue
0.4%
13.6%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
0.77×
2.21×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$37.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
FORM
FORM
Q1 26
$4.0M
$45.0M
Q4 25
$7.9M
$46.0M
Q3 25
$8.5M
$27.0M
Q2 25
$13.9M
$18.9M
Q1 25
$6.7M
$23.5M
Q4 24
$20.6M
$35.9M
Q3 24
$13.1M
$26.7M
Q2 24
$17.1M
$21.9M
Free Cash Flow
CLB
CLB
FORM
FORM
Q1 26
$517.0K
$30.7M
Q4 25
$5.0M
$34.7M
Q3 25
$6.5M
$19.5M
Q2 25
$10.4M
$-47.4M
Q1 25
$3.9M
$5.0M
Q4 24
$17.4M
$28.3M
Q3 24
$10.4M
$17.8M
Q2 24
$14.3M
$13.5M
FCF Margin
CLB
CLB
FORM
FORM
Q1 26
0.4%
13.6%
Q4 25
3.6%
16.1%
Q3 25
4.8%
9.6%
Q2 25
8.0%
-24.2%
Q1 25
3.1%
2.9%
Q4 24
13.4%
14.9%
Q3 24
7.7%
8.6%
Q2 24
10.9%
6.8%
Capex Intensity
CLB
CLB
FORM
FORM
Q1 26
6.7%
Q4 25
2.1%
5.3%
Q3 25
1.5%
3.7%
Q2 25
2.7%
33.8%
Q1 25
2.3%
10.8%
Q4 24
2.5%
4.0%
Q3 24
2.0%
4.3%
Q2 24
2.2%
4.3%
Cash Conversion
CLB
CLB
FORM
FORM
Q1 26
0.77×
2.21×
Q4 25
1.61×
1.98×
Q3 25
0.60×
1.72×
Q2 25
1.31×
2.08×
Q1 25
3.68×
Q4 24
2.78×
3.70×
Q3 24
1.12×
1.43×
Q2 24
1.90×
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons